Effects of melatonin on prepulse inhibition, habituation and sensitization of the human startle reflex in healthy volunteers

Psychiatry Research

Volumn 216, Issue 3, 2014, Pages 418-423

  Lehtinen, Emilia K ^a,b   Ucar, Ebru ^a,b   Glenthøj, Birte Y ^a,c   Oranje, Bob ^a,c,d  

^a Mental Health Center Glostrup   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Electromyography; Orbicularis oculi muscle; PPI; Schizophrenia; Sensorimotor gating

Indexed keywords

MELATONIN; PLACEBO; FOLIC ACID;

ADULT; ALERTNESS; ANALYSIS OF VARIANCE; ARTICLE; BRAIN DEPTH RECORDING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HABITUATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SENSITIZATION; SENSORY GATING; STARTLE REFLEX; VISUAL ANALOG SCALE; VOLUNTEER; ACTION POTENTIAL; CLINICAL EFFECTIVENESS; CROSSOVER PROCEDURE; DRUG EFFECT; ELECTROMYOGRAPHY; MORNING DOSAGE; SENSORIMOTOR FUNCTION; SUSTAINED DRUG RELEASE;

ELECTROMYOGRAPHY; ORBICULARIS OCULI MUSCLE; PPI; SCHIZOPHRENIA; SENSORIMOTOR GATING;

ADOLESCENT; ADULT; ATTENTION; CROSS-OVER STUDIES; HABITUATION, PSYCHOPHYSIOLOGIC; HEALTHY VOLUNTEERS; HUMANS; MALE; MELATONIN; SCHIZOPHRENIA; SENSORY GATING; STARTLE REACTION; YOUNG ADULT;

EID: 84899070594     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.02.030     Document Type: Article

References (69)

1. Abduljawad K.A., Langley R.W., Bradshaw C.M., Szabadi E. Effects of clonidine and diazepam on the acoustic startle response and on its inhibition by 'prepulses' in man. Journal of Psychopharmacology 1997, 11(1):29-34.
2. Abduljawad K.A., Langley R.W., Bradshaw C.M., Szabadi E. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man. Journal of Psychopharmacology 1998, 12(3):239-245.
3. Afonso P., Brissos S., Figueira M.L., Paiva T. Discrepant nocturnal melatonin levels in monozygotic twins discordant for schizophrenia and its impact on sleep. Schizophrenia Research 2010, 120(1-3):227-228.
4. Aggernaes B., Glenthoj B.Y., Ebdrup B.H., Rasmussen H., Lublin H., Oranje B. Sensorimotor gating and habituation in antipsychotic-naïve, first-episode schizophrenia patients before and after six months treatment with quetiapine. International Journal of Neuropsychopharmacology 2010, 13(10):1383-1395.
5. Anderson G., Maes M. Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects. Metabolic Brain Disorders 2012, 27(2):113-119.
6. Benson K.L. Sleep in schizophrenia: impairments, correlates, and treatment. Psychiatric Clinics of North America 2006, 29(4):1033-1045.
7. Binfare R.W., Mantovani M., Budni J., Santos A.R., Rodrigues A.L. Involvement of dopamine receptors in the antidepressant-like effect of melatonin in the tail suspension test. European Journal of Pharmacology 2010, 638(1-3):78-83.
8. Bitsios P., Giakoumaki S.G., Frangou S. The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values. Psychopharmacology 2005, 182(1):144-152.
9. Bleuler E. Die Schizophrenien (Dementia praecox). Lehrbuch der Psychiatrie 1937, 6:280-320. Springer J., Berlin.
10. Bond A., Lader M. The use of analog scales in rating subjective feelings. British Journal of Medical Psychology 1974, 47:211-218.
11. Braff D.L., Geyer M.A., Swerdlow N.R. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 2001, 156(2-3):234-258.
12. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Archives of General Psychiatry 1992, 49(3):206-215.
13. Braff D.L., Stone C., Callaway E., Geyer M.A., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978, 15(4):339-343.
14. Chemerinski E., Ho B.C., Flaum M., Arndt S., Fleming F., Andreasen N.C. Insomnia as a predictor for symptom worsening following antipsychotic withdrawal in schizophrenia. Comprehensive Psychiatry 2002, 43(5):393-396.
15. Csomor P.A., Stadler R.R., Feldon J., Yee B.K., Geyer M.A., Vollenweider F.X. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology 2008, 33(3):497-512.
16. Datta P.C., Hoehler F.K., Sandman C.A. Effects of melatonin on startle reflex in rat. Peptides 1981, 2(Suppl. 1):S155-S160.
17. Davis M. Pharmacological analysis of fear-potentiated startle. Brazilian Journal of Medical Biological Research 1993, 26(3):235-260.
18. Davis M., Astrachan D.I. Spinal modulation of acoustic startle: opposite effects of clonidine and d-amphetamine. Psychopharmacology 1981, 75(3):219-225.
19. Davis M., Svensson T.H., Aghajanian G.K. Effects of d- and l-amphetamine on habituation and sensitization of the acoustic startle response in rats. Psychopharmacologia 1975, 43(1):1-11.
20. Dawson M.E., Hazlett E.A., Filion D.L., Nuechterlein K.H., Schell A.M. Attention and schizophrenia: impaired modulation of the startle reflex. Journal of Abnormal Psychology 1993, 102(4):633-641.
21. DeMuro R.L., Nafziger A.N., Blask D.E., Menhinick A.M., Bertino J.S. The absolute bioavailability of oral melatonin. Journal of Clinical Pharmacology 2000, 40(7):781-784.
22. Dollins A.B., Lynch H.J., Wurtman R.J., Deng M.H., Kischka K.U., Gleason R.E., Lieberman H.R. Effect of pharmacological daytime doses of melatonin on human mood and performance. Psychopharmacology 1993, 112(4):490-496.
23. Duncan E., Szilagyi S., Schwartz M., Kunzova A., Negi S., Efferen T., Peselow E., Chakravorty S., Stephanides M., Harmon J., Bugarski-Kirola D., Gonzenbach S., Rotrosen J. Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol. Psychiatry Research 2003, 120(1):1-12.
24. Duncan E.J., Szilagyi S., Efferen T.R., Schwartz M.P., Parwani A., Chakravorty S., Madonick S.H., Kunzova A., Harmon J.W., Angrist B., Gonzenbach S., Rotrosen J.P. Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia. Psychopharmacology 2003, 167(1):63-71.
25. Fanget F., Claustrat B., Dalery J., Brun J., Terra J.L., Marie-Cardine M., Guyotat J. Nocturnal plasma melatonin levels in schizophrenic patients. Biological Psychiatry 1989, 25(4):499-501.
26. Filion D.L., Dawson M.E., Schell A.M. Modification of the acoustic startle-reflex eyeblink: a tool for investigating early and late attentional processes. Biological Psychology 1993, 35(3):185-200.
27. Geyer M.A., Braff D.L. Habituation of the blink reflex in normals and schizophrenic patients. Psychophysiology 1982, 19(1):1-6.
28. Graham F.K. The more or less startling effects of weak prestimulation. Psychophysiology 1975, 12(3):238-248.
29. Graham S.J., Langley R.W., Bradshaw C.M., Szabadi E. Effects of haloperidol and clozapine on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man. Journal of Psychopharmacology 2001, 15(4):243-250.
30. Graham S.J., Scaife J.C., Balboa Verduzco A.M., Langley R.W., Bradshaw C.M., Szabadi E. Effects of quetiapine and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. Journal of Psychopharmacology 2004, 18(2):173-180.
31. Jensen K.S., Oranje B., Wienberg M., Glenthoj B.Y. The effects of increased serotonergic activity on human sensory gating and its neural generators. Psychopharmacology 2008, 196(4):631-641.
32. Koch M. The neurobiology of startle. Progress in Neurobiology 1999, 59(2):107-128.
33. Kraepelin E. Psychiatrie, ein lehrbuch für studierende und ärzte. Klinische psychiatrie 1913, 8. Barth, J.A., Leipzig.
34. Kumari V., Mulligan O.F., Cotter P.A., Poon L., Toone B.K., Checkley S.A., Gray J.A. Effects of single oral administrations of haloperidol and d-amphetamine on prepulse inhibition of the acoustic startle reflex in healthy male volunteers. Behavioral Pharmacology 1998, 9(7):567-576.
35. Kumari V., Soni W., Mathew V.M., Sharma T. Prepulse inhibition of the startle response in men with schizophrenia - effects of age of onset of illness, symptoms, and medication. Archives of General Psychiatry 2000, 57(6):609-614.
36. Kumari V., Soni W., Sharma T. Normalization of information processing deficits in schizophrenia with clozapine. The American Journal of Psychiatry 1999, 156(7):1046-1051.
37. Lieberman H.R., Waldhauser F., Garfield G., Lynch H.J., Wurtman R.J. Effects of melatonin on human mood and performance. Brain Research 1984, 323(2):201-207.
38. Ludewig K., Geyer M.A., Vollenweider F.X. Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia. Biological Psychiatry 2003, 54(2):121-128.
39. Mackeprang T., Kristiansen K.T., Glenthoj B.Y. Effects of antipsychotics on prepulse inhibition of the startle response in drug-naive schizophrenic patients. Biological Psychiatry 2002, 52(9):863-873.
40. McGhie A., Chapman J. Disorders of attention and perception in early schizophrenia. British Journal of Medical Psychology 1961, 34:103-116.
41. Meincke U., Light G.A., Geyer M.A., Braff D.L., Gouzoulis-Mayfrank E. Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia. Psychiatry Research 2004, 126(1):51-61.
42. Mitchell H.A., Weinshenker D. Good night and good luck: norepinephrine in sleep pharmacology. Biochemical Pharmacology 2010, 79(6):801-809.
43. Monteleone P., Maj M., Fusco M., Kemali D., Reiter R.J. Depressed nocturnal plasma melatonin levels in drug-free paranoid schizophrenics. Schizophrenia Research 1992, 7(1):77-84.
44. Monteleone P., Natale M., La Rocca A., Maj M. Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics. Neuropsychobiology 1997, 36(4):159-163.
45. Morgan C.A., Southwick S.M., Grillon C., Davis M., Krystal J.H., Charney D.S. Yohimbine-facilitated acoustic startle reflex in humans. Psychopharmacology 1993, 110(3):342-346.
46. Nosjean O., Ferro M., Coge F., Beauverger P., Henlin J.M., Lefoulon F., Fauchere J.L., Delagrange P., Canet E., Boutin J.A. Identification of the melatonin-binding site MT3 as the quinone reductase 2. Journal of Biological Chemistry 2000, 275(40):31311-31317.
47. Oranje B., Glenthoj B. Clonidine normalizes sensorimotor gating deficits in patients with schizophrenia on stable medication. Schizophrenia Bulletin 2013, 39(3):684-691.
48. Oranje B., Jensen K., Wienberg M., Glenthoj B.Y. Divergent effects of increased serotonergic activity on psychophysiological parameters of human attention. International Journal of Neuropsychopharmacology 2008, 11(4):453-463.
49. Oranje B., Oel C.J., Gispen-de Wied C.C., Verbaten M.N., Kahn R.S. Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. Journal of Clinical Psychopharmacology 2002, 4(22):359-365.
50. Oranje B., Verbaten M.N., Kemner C., Kahn R.S. Modulating sensorimotor gating in healthy volunteers: the effects of desipramine and haloperidol. Psychiatry Research 2004, 127(3):195-205.
51. Pacchierotti C., Iapichino S., Bossini L., Pieraccini F., Castrogiovanni P. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Frontiers in Neuroendocrinology 2001, 22(1):18-32.
52. Perry W., Geyer M.A., Braff D.L. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. Archives of General Psychiatry 1999, 56(3):277-281.
53. Poulin J., Daoust A.M., Forest G., Stip E., Godbout R. Sleep architecture and its clinical correlates in first episode and neuroleptic-naive patients with schizophrenia. Schizophrenia Research 2003, 62(1-2):147-153.
54. Quednow B.B., Westheide J., Kuhn K.U., Werner P., Maier W., Hawellek B., Wagner M. Normal prepulse inhibition and habituation of acoustic startle response in suicidal depressive patients without psychotic symptoms. Journal of Affective Disorders 2006, 92(2-3):299-303.
55. Rawashdeh O., de Borsetti N.H., Roman G., Cahill G.M. Melatonin suppresses nighttime memory formation in zebrafish. Science 2007, 318(5853):1144-1146.
56. Reppert S.M., Godson C., Mahle C.D., Weaver D.R., Slaugenhaupt S.A., Gusella J.F. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proceedings of the National Academy of Sciences USA 1995, 92(19):8734-8738.
57. Reppert S.M., Weaver D.R., Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994, 13(5):1177-1185.
58. Robinson S., Rosca P., Durst R., Shai U., Ghinea C., Schmidt U., Nir I. Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients. Acta Psychiatrica Scandinavia 1991, 84(3):221-224.
59. Schachinger H., Blumenthal T.D., Richter S., Savaskan E., Wirz-Justice A., Krauchi K. Melatonin reduces arousal and startle responsiveness without influencing startle habituation or affective startle modulation in young women. Hormones and Behavior 2008, 54(2):258-262.
60. Schellekens A.F., Grootens K.P., Neef C., Movig K.L., Buitelaar J.K., Ellenbroek B., Verkes R.J. Effect of apomorphine on cognitive performance and sensorimotor gating in humans. Psychopharmacology 2010, 207(4):559-569.
61. Suresh Kumar P.N., Andrade C., Bhakta S.G., Singh N.M. Melatonin in schizophrenic outpatients with insomnia: a double-blind, placebo-controlled study. Journal of Clinical Psychiatry 2007, 68(2):237-241.
62. Swerdlow N.R., Eastvold A., Karban B., Ploum Y., Stephany N., Geyer M.A., Cadenhead K., Auerbach P.P. Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies. Psychopharmacology 2002, 161(2):189-201.
63. Swerdlow N.R., Mansbach R.S., Geyer M.A., Pulvirenti L., Koob G.F., Braff D.L. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology 1990, 100(3):413-416.
64. Swerdlow N.R., Stephany N., Shoemaker J.M., Ross L., Wasserman L.C., Talledo J., Auerbach P.P. Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross-species comparisons. Psychopharmacology 2002, 164(1):82-92.
65. Ucar E., Lehtinen E., Glenthøj B.Y., Oranje B. The effect of acute exogenous melatonin on P50 suppression in healthy male volunteers stratified for low and high gating levels. Journal of Psychopharmacology 2012, 26(8):1113-1118.
66. Uzbay T., Parlakpinar H., Akdag E., Celik T., Yararbas G., Ulusoy G., Acet A., Kose A., Kayir H. Chronic melatonin treatment reverses disruption of prepulse inhibition in pinealectomized and pinealectomized-plus-ovariectomized rats. Behavioral Brain Research 2013, 239:1-7.
67. van Luijtelaar G. The effects of diazepam on sensory gating in healthy volunteers. Neuroscience Letters 2003, 341(1):65-68.
68. Weil Z.M., Hotchkiss A.K., Gatien M.L., Pieke-Dahl S., Nelson R.J. Melatonin receptor (MT1) knockout mice display depression-like behaviors and deficits in sensorimotor gating. Brain Research Bulletin 2006, 68(6):425-429.
69. Wynn J.K., Green M.F., Sprock J., Light G.A., Widmark C., Reist C., Erhart S., Marder S.R., Mintz J., Braff D.L. Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial. Schizophrenia Research 2007, 95(1-3):134-142.